ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 228132 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 228132; 2) Community: the network communities that were significantly associated with the response to NSC 228132; 3) Molecule: the relationships between components within communities and NSC 228132; 4) MDR: the compounds that were significantly associated with the NSC 228132.

NSC Compound Enrichment Correlation
NSC 746087 1-(7-Fluoro-3-methyl-quinoxalin-2-yl)-3-(3,4,5-trimethoxy-phenyl)-propenone 0.0267520285931239 0.43196649
NSC 266047 1,2-Cyclohexanediamine, platinum complex, (1R-trans)- (9CI) 0.0278435641331422 0.25973572
NSC 31768 Null 0.0278435641331422 0.11013588
NSC 34533 Fulcin 0.0278435641331422 0.21925881
NSC 381811 Poly(oxy-1,2-ethanediyl), .alpha.-methyl-.omega.-[[3- (5-fluoro-1,2,3,4-tetrahydro-2,4-dioxo-1-pyrimidinyl)- 1-oxopropyl]oxy]- 0.0278435641331422 0.1146476
NSC 403572 Acetophenone, 4'-bromo-2-hydroxy-, benzoate (8CI) 0.0278435641331422 0.4873008
NSC 48229 Null 0.0278435641331422 -0.41235265
NSC 48300 ANTINEOPLASTIC-48300 0.0278435641331422 0.67870964
NSC 529108 4-Fluoro-D,L-tryptophan 0.0278435641331422 0.10119436
NSC 610456 Camptothecin Derivative 0.0278435641331422 0.23366097
Total:118  Current:79    [First] [Prev] [Next] [Last]